Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 (Q9838)
Revision as of 22:04, 20 May 2020 by Admin (talk | contribs) (Created claim: Property:P93: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study, #quickstatements; #temporary_batch_1590010982689)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fouladi M
0 references
2011
0 references
J. Clin. Oncol.
0 references
29
0 references
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
0 references
